A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens

Autor: Huang, David B., File, Thomas M., Jr, Torres, Antoni, Shorr, Andrew F., Wilcox, Mark H., Hadvary, Paul, Dryden, Matthew, Corey, G. Ralph
Zdroj: In Clinical Therapeutics August 2017 39(8):1706-1718
Databáze: ScienceDirect
Externí odkaz: